Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment

Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy

(2020) Julia Bespyatykh et al.   Pathogens

MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines

(2020) Dmitry A. Maslov et al.   Pathogens

Immune Phenotype and Functionality of Mtb-Specific T-Cells in HIV/TB Co-Infected Patients on Antiretroviral Treatment

(2020) Lucy Mupfumi et al.   Pathogens

Targeting Genome Integrity in Mycobacterium Tuberculosis: From Nucleotide Synthesis to DNA Replication and Repair

(2020) Riccardo Miggiano et al.   MOLECULES

Intelligent Mechanisms of Macrophage Apoptosis Subversion by Mycobacterium

(2020) Abualgasim Elgaili Abdalla et al.   Pathogens

Preclinical Evidence of Nanomedicine Formulation to Target Mycobacterium tuberculosis at Its Bone Marrow Niche

(2020) Jaishree Garhyan et al.   Pathogens

Genotyping, Assessment of Virulence and Antibacterial Resistance of the Rostov Strain of Mycobacterium tuberculosis Attributed to the Central Asia Outbreak Clade

(2020) Mikhail V. Fursov et al.   Pathogens

Genome Subtraction and Comparison for the Identification of Novel Drug Targets against Mycobacterium avium subsp. hominissuis

(2020) Reaz Uddin et al.   Pathogens

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

(2019) Michael J A Reid et al.   LANCET

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana

(2019) Tuelo Mogashoa et al.   Pathogens

Mycobacterium tuberculosis UvrB forms dimers in solution and interacts with UvrA in the absence of ligands

(2017) Samarpita Lahiri et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Biochemical and structural investigations on phosphoribosylpyrophosphate synthetase from Mycobacterium smegmatis

(2017) Stefano Donini et al.   PLoS One

Structural investigations on orotate phosphoribosyltransferase from Mycobacterium tuberculosis, a key enzyme of the de novo pyrimidine biosynthesis

(2017) Stefano Donini et al.   Scientific Reports

The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis

(2016) Vinayak Singh et al.   ACS Infectious Diseases

Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis

(2016) Yumi Park et al.   ACS Infectious Diseases

Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives

(2015) Pradeep Jadhavar et al.   CURRENT MEDICINAL CHEMISTRY

Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis

(2015) Alexander S. Pym et al.   EUROPEAN RESPIRATORY JOURNAL

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

(2013) Kevin Pethe et al.   NATURE MEDICINE